Narrow band UVB (311 nm), psoralen UVB (311 nm) and PUVA therapy in the treatment of early-stage mycosis fungoides: a right-left comparative study

2005 ◽  
Vol 21 (6) ◽  
pp. 281-286 ◽  
Author(s):  
M. El-Mofty ◽  
M. El-Darouty ◽  
M. Salonas ◽  
M. Bosseila ◽  
S. Sobeih ◽  
...  
Keyword(s):  
Comparative Study ◽  
Mycosis Fungoides ◽  
Narrow Band ◽  
Early Stage ◽  
Puva Therapy

Narrow-band UVB in the treatment of early stage mycosis fungoides: report of 16 patients

2005 ◽  
Vol 30 (4) ◽  
pp. 376-378 ◽  
Author(s):  
S. Z. Ghodsi ◽  
Z. Hallaji ◽  
K. Balighi ◽  
F. Safar ◽  
C. Chams-Davatchi
Keyword(s):  
Mycosis Fungoides ◽  
Narrow Band ◽  
Early Stage

P99 Broadband UVA versus PUVA in the treatment of early stage mycosis fungoides: a comparative study

2010 ◽  
Vol 20 ◽  
pp. e85 ◽  
Author(s):  
M. Fawzi ◽  
M. El Mofty ◽  
S. Ramadan ◽  
R. Hegazy ◽  
S. Sayed
Keyword(s):  
Comparative Study ◽  
Mycosis Fungoides ◽  
Early Stage

scholarly journals Narrow Band UVB Therapy in Early Stage Mycosis Fungoides. A Study of 23 Patients

2007 ◽  
Vol 98 (4) ◽  
pp. 259-264
Author(s):  
I.M. Coronel-Pérez ◽  
A.M. Carrizosa-Esquivel ◽  
F. Camacho-Martínez
Keyword(s):  
Mycosis Fungoides ◽  
Narrow Band ◽  
Early Stage

Narrow-band ultraviolet therapy in early-stage mycosis fungoides: study on 20 patients

2007 ◽  
Vol 23 (6) ◽  
pp. 229-233 ◽  
Author(s):  
V. Brazzelli ◽  
M. Antoninetti ◽  
S. Palazzini ◽  
F. Prestinari ◽  
G. Borroni
Keyword(s):  
Mycosis Fungoides ◽  
Narrow Band ◽  
Early Stage

ASSESSMENT OF KIDNEY FUNCTIONAL RESERVE ON THE BACKGROUND OF ANTI-AGGREGATE THERAPY IN CHRONIC KIDNEY DISEASE II-III STAGE

2020 ◽  
Vol 6 (1) ◽  
pp. 49-54
Author(s):  
Khabib Barnoev ◽  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Comparative Study ◽  
Early Stage ◽  
Raw Material ◽  
Functional Reserve ◽  
Functional Reserves ◽  
Term Administration ◽  
Antiaggregant Therapy

The article presents the results of a study to assess the functional reserve of the kidneys against the background of a comparative study of antiaggregant therapy dipyridamole and allthrombosepin in 50 patients with a relatively early stage of chronic kidney disease. Studies have shown that long-term administration of allthrombosepin to patients has resulted in better maintenance of kidney functional reserves. Therefore, our research has once again confirmed that diphtheridamol, which is widely used as an antiaggregant drug in chronic kidney disease, does not lag behind the domestic raw material allthrombosepin

Sign in / Sign up

Export Citation Format

Share Document